Log Rx – Trademark Portfolio

Entity Type: 03

Log Rx holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include LR, LOGRX, and LR LOG RX. The owner is based in Sacramento, CA.

2430 PAVILIONS PLACE LN. UNIT 306

Sacramento, CA 95825

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LOGRX
LOGRX
Registered 2024
LR LOG RX
LR LOG RX
Registered 2024
LR
LR
Registered 2024
LOGRX
LOGRX
Abandoned 2022

Trademark Classifications

Log Rx's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Log Rx have?

Log Rx has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.

What trademark classes does Log Rx file in?

Log Rx files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 9 (Computers & Electronics). Class 35 covers advertising; business management; business administration; office functions.

What are Log Rx's most well-known trademarks?

Log Rx's registered trademark portfolio includes well-known marks such as LR, LOGRX, and LR LOG RX. These are among 3 currently registered trademarks in the portfolio.

What is Log Rx's trademark registration success rate?

Log Rx has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.